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Edited by Jesus AvilaAbstract We recently established mouse microglial cells persis-
tently infected with mouse-adapted scrapie ME7 (ScMG20/
ME7) for in vitro study of prion pathogenesis. Here, we found
that ScMG20/ME7 cells were hypersensitive to P2X7 receptor
agonists, as demonstrated by sustained Ca2+ inﬂux, membrane
pore formation, cell death, and interleukin-1b release. P2X7
mRNA expression was upregulated in these cells, and also in
scrapie-infected mice brains. Treatment with pentosan polysul-
fate eliminated the infectivity and disease-related forms of prion
protein from ScMG20/ME7 cell cultures, however, hypersensi-
tivity of P2X7 receptors remained. These results suggest that
prion infections may strongly aﬀect the P2X7 receptor system
in mouse microglial cells.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Prion diseases are fatal neurodegenerative disorders, causing
brain vacuolation, neuronal cell death, astrocytosis, and
microgliosis [1,2]. Pathogenesis in the brain is associated with
an accumulation of abnormal forms of prion protein (PrPSc)
[3], which is thought to be the main constituent of the causative
agent of the diseases. PrPSc has diﬀerent biophysical and bio-
chemical properties from the normal prion protein (PrPC),
such as a conformational change from a helical structure to
a b-sheet and an increased resistance to proteases [4]. In path-
ological brains, the accumulation of PrPSc coincided with the
appearance of reactive microglia and astrocytes, and was oftenAbbreviations: PrP, prion protein; P2X7R, P2X7 receptor; IL-1b,
interleukin-1b; PK, protenase K; LPS, lipopolysaccharide; BBG,
brilliant blue-G; PPS, pentosan polysulfate; BSA, bovine serum
albumin
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are frequently found in the vicinity of PrPSc aggregates [7,8],
these cells are suggested to play an important role in the path-
ogenesis of prion diseases.
The P2X7 receptor (P2X7R) is one of the major ATP-gated
ion channels expressed in microglia [9], and transduces ATP-
mediated signals to these cells to respond to physiological
and pathological changes in the brain. ATP interacts with
P2X7R with less aﬃnity than for other purinergic receptors,
and induces several cellular responses, such as Ca2+ inﬂux, for-
mation of large non-selective membrane pores, induction of
microglial cell death, and release of mature interleukin-1b
(IL-1b) [10–15]. The expression of P2X7R is upregulated in
microglia in the brain of Alzheimer’s disease (AD) patients
[16] and in the brain of an AD model mouse [17]. Also, upreg-
ulation of P2X7R expression on neurons and glial cells is re-
ported during the course of cerebral ischemia in rats [18]. In
addition, P2X7R becomes hypersensitive in cerebrocortical cell
cultures which are exposed to glucose-free medium saturated
with argon, as an in vitro ischemia model [19]. As overacti-
vated microglia produce various neurotoxic substances and
are possibly involved in neuronal death in several neurodegen-
erative diseases [20], these studies raise hypothesis that the
activation of P2X7R in microglial cells correlates with neuro-
pathogenic processes in the brain.
Recently, we have established a mouse microglial cell line
persistently infected with mouse-adapted scrapie ME7 strain
[21]. In this study, as an attempt to characterize cellular alter-
ations in prion-infected microglial cells, we investigated
P2X7R functions in these cells. Scrapie-infected microglia
showed hypersensitivity of P2X7R functions, as demonstrated
by an increase in the intracellular Ca2+ concentration ([Ca2+]i),
the formation of pores in the cell membrane, the induction of
microglial cell death, and the release of mature IL-1b. Further-
more, we demonstrated upregulation of P2X7R mRNA in the
brains of scrapie-infected mice.2. Materials and methods
2.1. Reagents
All reagents were obtained from Sigma (St. Louis, MO) unless
otherwise noted.blished by Elsevier B.V. All rights reserved.
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An immortalized mouse microglial cell line (MG20) was established
from PrPC-overexpressing mice as described previously [15,21]. MG20
cells expressed approximately ninefold higher PrP levels than a C57BL/
6 mouse microglial cell line, MG6 [21]. The infection of MG20 cells
with the ME7 scrapie was performed, and infected cells were routinely
cultured as described previously [21].
2.3. Measurement of [Ca2+]i
After washing, the cells were resuspended in HEPES-buﬀered salt
solution [HBSS: 145 mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, 20 mM HEPES, 10 mM glucose, and 0.2% bovine serum albu-
min (BSA), pH 7.4]. The [Ca2+]i was measured at 30 C using Fura 2
ﬂuorescence as described previously [15,22–24]. The Fura 2-loaded
cells were excited at 340 nm and 380 nm, and ﬂuorescence was mea-
sured at 500 nm. The change in [Ca2+]i was expressed as ratio of the
ﬂuorescence intensity (F340/F380). At 5 min after the stimulation,
the rise in [Ca2+]i above basal levels was calculated from the ﬂuores-
cence ratio F340/F380 as described previously [15]. Each [Ca2+]i mea-
surement was repeated at least three times.
2.4. YO-PRO-1 uptake
The cells were plated in 8-well chamber glass slides (2.5 · 104 cells/
well). Next day, the medium was replaced with HBSS containing
20 lM YO-PRO-1 iodide (YO-PRO-1) (Invitrogen, Carlsbad, CA),
and nucleotides (ATP and BzATP) or 100 lg/ml saponin were added.
The cells were further incubated for 15 min at room temperature.
Then, the cells were observed with a Zeiss LSM520 inversed laser scan-
ning microscope.
2.5. IL-1b release and WST-1 cell viability assay
The cells were plated on 96-well plates at a density of 5 · 103 cells/
well with 100 ll of culture medium. Next day, the cells were primed
with culture medium containing 1 lg/ml lipopolysaccharide (LPS) for
6 h, washed with PBS (), and further incubated with each concentra-
tion of ATP in minimum essential medium (MEM) containing 0.02%
BSA for 1.5 h. The medium (50 ll) was collected and centrifuged
brieﬂy to remove cellular debris for subsequent immunoblot analysis
of IL-1b. Then, 60 ll of MEM containing 10 ll of WST-1 solution
(Cell Counting Kit-8, Dojindo, Kumamoto, Japan) was added and
incubated for another 30 min. The absorbance was measured with a
plate reader at a wavelength of 450 nm. The experiments were per-
formed in triplicate, and the data were shown as mean percentages
of the control absorbance (no-treatment).2.6. Mouse bioassay
CD-1 mice were injected intracerebrally with Obihiro scrapie-in-
fected or normal mouse brain homogenates [10% (w/v)] and sacriﬁced
for the isolation of total RNA on days 10, 30, 60, 90, 120 and 150 after
infection. All mouse were kept in an air-conditioned room and fed on
standard laboratory food pellets and water ad libitum. The present
study was done according to the Guideline for Animal Experiments
of National Institute of Animal Health (Tsukuba, Japan).
The infectivity associated with pentosan polysulfate (PPS)-treated
and untreated ScMG20/ME7 cell cultures was assayed by intracerebral
inoculations into tga20 mice as described previously [21]. ScMG20/
ME7 cells were treated with 200 lg/ml PPS (ORTHO-McNEIL, Rari-
tan, NJ) for 2 weeks, and then cultured for another 3 weeks in PPS-free
medium.2.7. Quantitative real time reverse transcription-polymerase chain
reaction (Q-PCR) analysis
The mRNA levels were assessed by Q-PCR. Total RNA fromMG20
cells or CD-1 mouse brains was prepared using the RNAgents Total
RNA Isolation System (Promega, Madison, WI) according to the
manufacturer’s instructions. After DNaseI treatment, total RNA from
three individual mouse brains were put together for normalization and
reverse transcription was carried out on 1 lg total RNA using Rever-
Tra Ace a as described by the manufacturer (Toyobo, Osaka, Japan).
cDNA (20 ng) was diluted with a polymerase chain reaction mix
(SYBR Premix Ex Taq, Takara, Osaka, Japan) containing a ﬁnal con-
centration of 0.2 lM of primers in a ﬁnal volume of 20 ll. The primer
pairs were selected from ‘PrimerBank’ (http://pga.mgh.harvard.edu/primerbank/). The sequences of P2X7R primers were as follows:
forward 5 0-GACAAACAAAGTCACCCGGAT-3 0 and reverse 5 0-
CGCTCACCAAAGCAAAGCTAAT-3 0 (GenBank accession no.
NM011027). The glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA was used as an endogenous control, and the primer
sequences were as follows: forward 5 0-AGGTCGGTGTGAACG-
GATTTG-3 0 and reverse 5 0-TGTAGACCATGTAGTTGAGGTCA-
3 0. The thermal cycler parameters were as follows: hold for 30 s at
95 C for one cycle followed by ampliﬁcation of cDNA for 40 cycles
with melting for 5 s at 95 C, and annealing and extension for 40 s at
60 C. All the reactions were performed in triplicate and analyzed
using an ABI Prism 7500 detection system (Applied Biosystems).
Absolute quantiﬁcation of P2X7R mRNA was obtained using a stan-
dard curve method [25]. PCR fragments ampliﬁed by RT-PCR using
total RNA and the Q-PCR primer pair were used to prepare absolute
standards. The copy number of the unknown samples was normalized
to GAPDH mRNA and expressed relative to a calibrator sample
(mock-treated mice or cells).
2.8. Immunoblot analysis
Protenase K (PK)-treated PrPSc was puriﬁed from ScMG20/ME7
cells and Obihiro scrapie-infected mice brains, and evaluated by immu-
noblot analysis as described previously using anti-PrP mAb T2 [21,26].
To detect the mature processing and release of IL-1b or P2X7R pro-
tein, 10 ll of culture medium or cell lysate (2.5 · 105 cells equivalent
per lane) was also resolved by 12% SDS–PAGE and electroblotted
onto a polyvinylidene ﬂuoride (PVDF) membrane. After blocking with
5% non-fat milk for 1 h, the blots were reacted with biotinylated anti-
IL-1b antibody (R&D Systems, Minneapolis, MN) (1:1000) or anti-
P2X7R rabbit polyclonal antibody (Sigma, P8232) (1:1000) for 1 h.
After washing, the blots were incubated with HRP-streptavidin conju-
gate (Zymed, South San Francisco, CA) (1:5000) for 20 min or HRP-
conjugated goat anti-rabbit antibody (1:20000) for 1 h, and then devel-
oped using Super Signal West Dura (Pierce, Rockford, IL). All blots
were imaged with a Fluorchem (Alpha Innotech, San Leandro, CA)
according to the manufacturer’s instructions.
2.9. Immunohistochemical analysis
Mouse brains were ﬁxed with 10% neutral buﬀered formalin, dehy-
drated, and then embedded in paraﬃn. The sections were cut at 5 lm
on microtome and mounted onto silane coated slides. Sections were
autoclaved in citrate buﬀer (pH 6.0) for 5 min at 121 C. After washing
with PBS, sections were incubated with 1% goat serum for 30 min and
then incubated with a rabbit polyclonal antibody against Iba1 protein
(1:400) as a marker of mouse microglial cells for 1 h (Wako, Osaka, Ja-
pan). Sections were washed and incubated with Alexa Fluor 546-con-
jugated goat anti-rabbit antibody (1:400) for 1 h, then observed with a
ﬂuorescence microscope.
2.10. Statistical analysis
Values in the ﬁgures are expressed as means ± S.E.M. To determine
statistical signiﬁcance, Students t-test for unpaired data was applied as
appropriate. A value of P < 0.05 was considered signiﬁcant.3. Results
3.1. Hypersensitivity of P2X7R-mediated [Ca2+]i related-
response in ScMG20/ME7 cells
A representative subclone of MG20 cells persistently in-
fected with ME7 scrapie (ScMG20/ME7) showed a substantial
accumulation of PrPSc, and was used in this study. MG20 cells
similarly exposed to the brain homogenate from normal mice
were used as a mock-treated control (MG20/mock).
In MG20/mock, 1 mM ATP induced a biphasic response, a
weak transient increase followed by a robust sustained increase
in [Ca2+]i (Fig. 1A). The response induced by ATP in MG20
cells was similar to that in the wild-type MG6 microglial cells
established from C57BL/6 mice [15]. MG20 cells express nine-
times more PrPC than MG6 cells [21], however, overexpression
Fig. 1. Changes in [Ca2+]i in MG20/mock and ScMG20/ME7 cells. Fura 2-loaded cells were suspended in HBSS and the ﬂuorescence ratio F340/
F380 was monitored as the change in [Ca2+]i. MG20/mock (A, B) and ScMG20/ME7 (C, D) cells were treated with ATP (A, C) and BzATP (B, D) at
the concentrations indicated. The sustained [Ca2+]i elevation induced by ATP and BzATP in ScMG20/ME7 cells was inhibited by 20 lM BBG and
100 lMCuCl2 (E, F). At the end of each measurement, the cells were permeabilized with 0.2% Triton-X 100 for calibration of Fura 2 loading (closed
triangles). The rise in [Ca2+]i above basal levels was calculated from the ﬂuorescence ratio F340/F380 at 5 min after the stimulation with 500 lMATP
and 200 lM BzATP in MG20/mock (mock) and ScMG20/ME7 (ScMG20) cells (G). The [Ca2+]i values are shown as means ± S.E.M. (n = 4).
Signiﬁcant diﬀerences at P-values of <0.01 (*) between MG20/mock and ScMG20/ME7 cells are indicated.
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[Ca2+]i in this microglial cell line. It has been pharmacologi-
cally conﬁrmed that the ﬁrst weak transient phase was mainly
involved in the release of Ca2+ from intracellular stores
through G protein-coupled P2Y receptor activation, whereas
the second sustained phase was mainly elicited by the activa-
tion of P2X7 receptor channels [15]. Accordingly, BzATP,
known as a selective P2X7R agonist, induced only a sustained
increase in [Ca2+]i in MG20/mock cells at 400 lM (Fig. 1B).
The sustained response in these cells was not evoked at lower
concentrations, such as 500 lM ATP or 200 lM BzATP
(Fig. 1A, B), as similar to MG6 cells [15,27]. In contrast, scra-
pie-infected ScMG20/ME7 cells responded to these lower con-
centrations of ATP and BzATP (Fig. 1C, D). The sustained
increase in [Ca2+]i induced by ATP and BzATP was completely
abolished when the extracellular Ca2+ in the cell suspension
was depleted (data not shown), suggesting an inﬂux of extra-
cellular Ca2+ through the membrane ion channels. No desensi-
tization of the sustained increase in [Ca2+]i was observed in
these cells during the experimental periods up to 10 min(Fig. 1C, D), supporting the possible involvement of P2X7R
which is little susceptible to desensitization [28]. Brilliant
blue-G (BBG) is an antagonist of P2X7R [29], and potently
inhibited the sustained rise in [Ca2+]i induced by ATP and
BzATP in ScMG20/ME7 cells at 20 lM (Fig. 1E, F). In addi-
tion, CuCl2 also depressed the sustained increase in [Ca
2+]i at
100 lM (Fig. 1E, F), consistent with the ﬁnding that P2X7R
function is inhibited by divalent cations including copper
[30]. The rise in [Ca2+]i induced by 500 lM ATP or 200 lM
BzATP in ScMG20/ME7 cells was signiﬁcantly enhanced com-
pared to that in MG20/mock cells (Fig. 1G). The enhanced
Ca2+ response in ScMG20/ME7 cells was regularly conﬁrmed
at several passages after subcloning, and accumulation of
PrPSc was also checked by immunoblotting (data not shown).
These results suggest that ScMG20/ME7 cells exhibit hyper-
sensitivity in P2X7 receptor function compared to mock-trea-
ted control cells.
ScMG20/ME7 cells were obtained from a subpopulation of
MG20 cells after infection with the scrapie strain ME7. Thus,
it might be possible that the hypersensitivity of P2X7R is
3022 T. Takenouchi et al. / FEBS Letters 581 (2007) 3019–3026attributed to the selection of a novel microglial clone after an
infection with the speciﬁc scrapie strain. However, MG20 cells
persistently infected with the scrapie Obihiro strain showed the
similar degree of hypersensitivity to ATP and BzATP as
ScMG20/ME7 cells (data not shown). In addition, none of
the 12 subclones randomly isolated from mock-treated
MG20 cells showed hypersensitivity in the sustained response
to ATP and BzATP (data not shown). So, the hypersensitivity
of P2X7R function would have been resulted from the persis-
tent scrapie infection in mouse microglial cells, rather than by
clonal selection.Fig. 2. Uptake of YO-PRO-1, release of IL-1b and induction of cell
death induced by ATP or BzATP, and expression of P2X7R in MG20/
mock and ScMG20/ME7 cells. MG20/mock (A–D) and ScMG20/ME7
(E–H) cells were plated in 8-well chamber glass slides. The medium was
changed to HBSS containing 20 lM YO-PRO-1, and then the cells
were stimulated with 500 lMATP (B, F) and BzATP (C, G). The cells
were cultured with (A, E) or without (D, H) 100 lg/ml saponin. After
15 min of incubation, the cells were observed under a laser scanning
microscope (Scale bar = 100 lm). The processing and release of IL-1b
was assessed by immunoblotting of the supernatant from MG20/mock
and ScMG20/ME7 cell culture treated with ATP at the indicated
concentrations (I). The cell death induced by the indicated concentra-
tions of ATP was assessed by WST-1 colorimetric assay as described in
Section 2 (J). Q-PCR analysis performed in triplicate showed that the
expression of P2X7R mRNA was upregulated in ScMG20/ME7 cells
(ME7) compared to MG20/mock cells (mock) (K). The upregulation
of P2X7R protein in ScMG20/ME7 cells was also detected by
immunoblotting with anti-P2X7R antibody (2.5 · 105 cells equivalent
per lane) (L). Signiﬁcant diﬀerences at a P-value of <0.01 (*) between3.2. Uptake of YO-PRO-1, release of IL-1b and induction of
microglial cell death mediated by P2X7R activation in
ScMG20/ME7 cells
Activation of P2X7R results in the formation of membrane
pores [13], which can be evaluated by the inﬂux of a ﬂuorescent
dye such as YO-PRO-1. As shown in the positive control, a
signiﬁcant inﬂux of YO-PRO-1 was detected in all of the
MG20/mock and ScMG20/ME7 cells permeabilized by the
treatment with 200 lg/ml saponin (Fig. 2A, E), but not in un-
treated cells (Fig. 2D, H). After the application of 500 lM
ATP (Fig. 2B, F) and 500 lM BzATP (Fig. 2C, G), signiﬁcant
uptake of YO-PRO-1 was induced in most ScMG20/ME7
cells, but not in MG20/mock cells. The activation of P2X7R
plays a crucial role in the maturation and release of IL-1b in
microglial cells [14]. IL-1b is synthesized as 31–34-kDa procy-
tokines (pro-IL-1b) and then converted into the mature 17-
kDa form. LPS treatment is required to elicit the release of ma-
ture IL-1b through the activation of P2X7R. A remarkable in-
crease in the release of pro-IL-1b and processed mature IL-1b
was induced by the addition of more than 1 mM ATP in
ScMG20/ME7 cells primed with LPS, but not in LPS-primed
MG20/mock cells (Fig. 2I). The formation of pores caused
by the prolonged activation of P2X7R eventually results in
the death of microglial cells [10,11]. Therefore, we examined
the ATP-induced death in these cells using WST-1 cell viability
assay [31]. After treatment with 2 mM ATP, cell death was sig-
niﬁcantly induced in ScMG20/ME7 cells compared to MG20/
mock cells in our experimental condition (Fig. 2J). These re-
sults are well consistent with the hypersensitivity of the
P2X7R-mediated change in [Ca2+]i in ScMG20/ME7 cells.
Thus, our ﬁndings strongly support the notion that P2X7R
system became more sensitive in scrapie-infected MG20 cells
than mock-treated control cells.
MG20/mock and ScMG20/ME7 cells are indicated in J and K.3.3. Upregulation of P2X7R expression in ScMG20/ME7 cells
and scrapie-infected mouse brains
To determine whether the hypersensitivity of P2X7R is asso-
ciated with the upregulation of the receptor’s expression in
scrapie-infected microglia, the expression levels of P2X7R
mRNA were compared by Q-PCR. Expression of P2X7R
mRNA in ScMG20/ME7 cells was upregulated approximately
sixfold compared to that in MG20/mock cells (Fig. 2K). The
upregulation of P2X7R protein was also conﬁrmed by immu-
noblotting (Fig. 2L). These ﬁndings suggest that the hypersen-
sitivity of P2X7R in scrapie-infected cells may be at least in
part due to the increased expression of the receptor protein.
To conﬁrm whether PrPSc infection correlates with the
upregulation of P2X7R mRNA expression in vivo, we exam-
ined the levels of the receptor mRNA in scrapie-infectedmouse brains by Q-PCR. We isolated total RNA from brains
of mock-treated or Obihiro scrapie-infected mice on days 10,
30, 60, 90, 120, and 150 after infection. The expression of
P2X7R in the brains of scrapie-infected mice increased slightly
on day 120, and then by twofold on day 150 post-infection
(Fig. 3A). PK-resistant PrPSc was detected at around 60–90
days, and the signal intensity increased from 120 to 150 days
after infection (Fig. 3B). These results suggest that PrPSc accu-
mulation coincided with upregulation the expression of
P2X7R mRNA in mouse brains. In mock-treated mouse hip-
pocampus, microglia exhibited a predominantly ramiﬁed mor-
phology characterized by their small somas and long and
slender processes, as shown by immunostaining with anti-
Iba1 antibody which speciﬁcally stains microglia in the brain
Fig. 3. Q-PCR analysis of P2X7R mRNA expression, immunoblotting
of PrPSc, and immunostaining of microglia in scrapie-infected mouse
brains. Total RNA was prepared from CD-1 mouse brains on days 10,
30, 60, 90, 120, and 150 after infection with the scrapie Obihiro strain.
The total RNA extracted from three individual mouse brains were
pooled on each incubation period and applied for Q-PCR. Q-PCR
analysis was performed as described in Section 2 using speciﬁc primer
pairs for mouse P2X7R (A). PK-resistant PrPSc was detected with
immunoblotting around 60–90 days and its intensity increased towards
150 days after the infection (B). Microglia were immunostained with
anti-Iba1 antibody in mock-treated and scrapie-infected mouse
hippocampus (day 150 after infection), and observed under a ﬂuores-
cence microscope (C). Scale bar = 50 lm.
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fected mouse hippocampus exhibited a primarily ameboid-like
activated morphology with enlarged cell bodies and a few
stumpy processes (Fig. 3C). In Alzheimer’s disease brains,
the morphological change and the increase in the number of
ameboid-shaped microglia are closely associated with the
upregulation of P2X7R expression [16]. Therefore, the increase
in P2X7R mRNA levels, the accumulation of PrPSc, and the
microglial cell activation in the scrapie-infected mouse brain
collectively suggest that P2X7R is also upregulated in microg-
lial cells during scrapie infection in vivo.
3.4. PPS treatment reduced PrPSc infection in ScMG20/ME7
cells, but did not aﬀect the hypersensitivity of the P2X7R
system
The amount of PrPSc was greatly reduced in ScMG20/ME7
cells after treatment with 200 lg/ml PPS (Fig. 4A, left panel),
as reported previously [32]. Concomitantly, mice inoculated
intracerebrally with PPS-treated cells did not show clinical
signs of scrapie after 350 days, whereas mice inoculated with
untreated cells developed typical symptoms of scrapie and died
at 61.3 ± 4.6 days (means ± S.D.).
The expression of P2X7R mRNA and P2X7 receptor-medi-
ated increase in [Ca2+]i were assessed in these PPS-curedScMG20/ME7 cells. The expression of P2X7R mRNA was still
upregulated compared to that in MG20/mock cells (Fig. 4B).
The PPS-cured cells still showed similar hypersensitivity to
both ATP and BzATP (Fig. 4C), as the uncured ScMG20/
ME7 cells. PPS treatment weakly enhanced the sustained
Ca2+ inﬂux induced by ATP and BzATP in MG20/mock cells
(Fig. 4D, trace a) compared to no-treated cells (Fig. 4D, trace
b), but levels returned to normal after one week of culture in
PPS-free medium (Fig. 4D, trace c), suggesting that a direct ef-
fect of PPS on microglial P2X7R sensitivity can be excluded in
PPS-cured ScMG20/ME7. These results suggest that persistent
infection of PrPSc in microglia might have strongly aﬀected
P2X7R sensitivity, which is not reverted after the treatment
with PPS.3.5. Hypersensitivity of P2X7R returned to normal in self-cured
ScMG20/ME7 cells after long culture periods
Persistently infected cells, such as ScN2a and ScN1E-115
cells, often lose the PrPSc after long culture periods, and these
‘‘self-cured’’ cells were used as excellent controls for the char-
acterization of PrPSc-infected cells [33]. In fact, we obtained
such self-cured ScMG20/ME7 subclone after 43 passages.
PrPSc was spontaneously reduced in these cells (Fig. 4A, right
panel). Therefore, we also examined the expression of P2X7R
mRNA and P2X7 receptor-mediated Ca2+ response in these
self-cured cells. Both expression of P2X7R mRNA and sensi-
tivity of P2X7R to ATP and BzATP returned to normal lev-
els, suggesting the close correlation of hypersensitivity of
P2X7R system with PrPSc infection in these self-cured cells
(Fig. 4B, E).4. Discussion
In this paper, we report for the ﬁrst time that prion infection
closely correlated with the hypersensitivity of P2X7R, as well
as an upregulation of the receptor’s expression in mouse
microglial cells. No such hypersensitivity has been observed
in subclones of mock-treated cells or other wild-type mouse
microglial cells in our laboratory [15,27], strongly suggesting
that the alteration of P2X7R is a result of scrapie-infection,
rather than a clonal selection of the cells. The in vivo ﬁndings
that P2X7R mRNA increased in scrapie-infected mouse brains
along with microglial cell activation further supports the corre-
lation between PrPSc infection and the upregulation of P2X7R
expression. So, ScMG20/ME7 cells may provide a useful cellu-
lar model to investigate the biological relevance of prion infec-
tion to the alteration of cellular responses, such as P2X7R
functions in microglial cells.
The mechanism by which PrPSc infection upregulates the
P2X7R expression in MG20 cells remains to be elucidated.
As cultured human fetal microglia exposed to amyloid b-pep-
tide (Ab) had elevated expression levels of P2X7R mRNA and
an enhanced increase in [Ca2+]i caused by BzATP [16], amy-
loidgenic proteins, such as Ab and PrPSc, might have common
property to upregulate microglial P2X7R. In addition, as the
expression of P2X7R was upregulated by treatment with sev-
eral cytokines, such as IL-1b [34], interferon-c and tumor
necrosis factor-a (TNF-a) [35], a imbalance of the cytokine
network might be involved in the modulation of P2X7R
expression in scrapie-infected MG20 cells. The abnormality
Fig. 4. Detection of PrPSc, expression of P2X7R mRNA, and P2X7R-mediated Ca2+ response in PPS-treated and self-cured ScMG20/ME7 cells.
ScMG20/ME7 cells were incubated with or without 200 lg/ml of PPS for 2 weeks, and further cultured for 3 weeks in PPS-free medium. The cell
extracts treated with PK were analyzed by immunoblotting with T2 monoclonal antibody (2.5 · 105 cells equivalent per lane). PrPSc was greatly
reduced in ScMG20/ME7 cells by PPS treatment (A, left panel). PrPSc was also spontaneously cleared in ScMG20/ME7 cells cultured after 43
passages (self-cured) (A, right panel). Q-PCR analysis performed in triplicate showed that the expression of P2X7R mRNA was still upregulated in
PPS-cured ScMG20/ME7 cells (PPS-cured ME7), but returned to normal level in self-cured cells (self-cured) (B). Signiﬁcant diﬀerences at a P-value
of <0.01 (*) between MG20/mock (mock) and PPS-cured ScMG20/ME7 cells are indicated. Fura 2 was loaded into PPS-treated MG20/mock, PPS-
cured and self-cured ScMG20/ME7 cells, and [Ca2+]i-associated ﬂuorescence was monitored with a spectroﬂuorometer. Cells were treated with ATP
or BzATP at the concentrations indicated. Hypersensitivity of P2X7R still remained in PPS-cured cells (C). Treatment with PPS for 1 week slightly
enhances the sensitivity of P2X7R to ATP (trace a, in D upper) and BzATP (trace a, in D lower) compared to control cells (trace b, in D upper and
lower) in MG20/mock cells. However, the eﬀect of PPS was disappeared after further 1 week incubation with PPS-free medium (trace c, in D upper
and lower). The sensitivity of P2X7R to ATP and BzATP returned to normal level in self-cured cells (E). At the end of each measurement, the cells
were permeabilized with 0.2% Triton-X 100 for calibration of Fura 2 loading (closed triangles).
3024 T. Takenouchi et al. / FEBS Letters 581 (2007) 3019–3026of several cytokine systems including IL-1b and TNF-a is dem-
onstrated in microglia in prion diseases [36,37]. Therefore,
PrPSc infection may modify some cytokine systems in the
microglial cells, thus altering the expression of P2X7R protein
and its responsiveness.
Some studies have proposed that the alteration of calcium
channels in neuronal cells caused by production of PrPSc
and/or reduction of PrPC is involved in neurodegeneration in
prion diseases. PrPC is reported to be associated with the reg-
ulation of intracellular free Ca2+ levels through interaction
with voltage-sensitive calcium channels [38]. Recombinant
PrPC modulated the L-type voltage-gated calcium channels
in cultured mouse cerebellar granule cells [39]. Furthermore,
PrPSc infection caused a malfunction of voltage-gated N-type
calcium channels in scrapie-infected GT1-1 cells [40]. In our
study, overexpression of PrPC did not aﬀect the P2X7R-medi-
ated change in [Ca2+]i in MG20 microglial cells, but PrP
Sc
accumulation on cell membrane may have aﬀected the sensitiv-
ity of P2X7R expressed in ScMG20/ME7 cells. Regarding this,
we have recently reported that P2X7R becomes more sensitive
to the agonists in mouse microglial cells treated with lysophos-phatidylcholine (LPC), which aﬀects the mechanical properties
of cell membrane [27]. So, PrPSc may similarly aﬀect the mem-
brane properties of microglia, or change the microglial cell
metabolism to produce inﬂammatory lipids, including LPC.
Our ﬁndings suggest that PrPSc infection alters membrane cat-
ion channels not only in neuronal cells but also in microglia,
which results in dysregulation of microglial functions leading
to the neuronal damage in prion diseases.
Whereas treatment with PPS eliminated infectivity and PrPSc
from the ScMG20/ME7 cell culture as demonstrated by the
mouse bioassay and immunoblotting, the sensitivity of
P2X7R remained high in PPS-cured cells. The alteration of
P2X7R system might not be reversed solely by the rapid clear-
ance of PrPSc with PPS treatment. In contrast, sensitivity of
P2X7R returned to normal level in self-cured ScMG20/ME7
cell. Although the mechanisms by which infected cells sponta-
neously lose PrPSc remain unknown [33], P2X7R system might
have restored during the long culture, in correlation to a grad-
ual clearance of PrPSc in self-cured ScMG20/ME7 cells. The
discrepancy between the P2X7R responses in the two types
of cured cells is not fully explained yet. However, one postu-
T. Takenouchi et al. / FEBS Letters 581 (2007) 3019–3026 3025lated mechanism of PPS for the inhibition of PrPSc propaga-
tion is to enhance the rate of endocytosis of PrPC and thereby
decrease the amount of PrPC on the cell surface [41]. Since PPS
does not directly degradate PrPSc in persistently infected cells,
it is speculated that trace amount of PrPSc which is below the
detection limits by immunoblotting or bioassay but suﬃcient
for aﬀecting the sensitivity of the P2X7R system may still exist
in PPS-cured cells. Highly sensitive detection techniques of
PrPSc such as protein misfolding cyclic ampliﬁcation (PMCA)
[42] may reveal the presence of the residual PrPSc in the PPS-
cured cells, and give a clue to explain the discrepancies of
P2X7R sensitivity between the two types of cells.
In conclusion, this study provides an intriguing scenario,
that PrPSc-related upregulation of microglial P2X7R expres-
sion and its hypersenstitivity to the agonists are involved in
the pathogenesis of prion diseases. P2X7R plays important
roles in microglial activation and overactivation of this recep-
tor elicits abnormal inﬂammatory responses in the brain,
which lead to neurodegeneration. If so, the P2X7R system
may be a therapeutic target for neurodegenerative diseases,
including prion diseases.
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